AMRI (NASDAQ: AMRI) will report second quarter results after the close
of the market on Tuesday, August 4, 2009. The company will subsequently
hold a conference call on Wednesday, August 5, 2009 at 10 a.m. EDT to
discuss quarterly financial results.
To listen to the conference call, dial 888-539-3686 (for domestic calls)
or 719-325-2323 (for international calls) at 9:45 a.m. EDT and provide
conference code 1479331. In addition, the call is being webcast on the
Internet and can be accessed on the company's website, www.amriglobal.com.
Replays of the call will be available for seven days following the call
beginning at noon on August 5, 2009. To access the replay by telephone,
dial 888-203-1112 (for domestic calls) or 719-457-0820 (for
international calls) and use passcode 1479331. Replays of the call will
also be available as a webcast for three months in the investor area of
the company's website at www.amriglobal.com/investor_relations/.
Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides
scientific services, products and technologies focused on improving the
quality of life. AMRI works on drug discovery and development projects
and conducts manufacturing of active ingredients and pharmaceutical
intermediates for many of the world's leading healthcare companies. As
an additional value added service to its customers, the company is also
investing in R&D in order to expand its contract services and to
identify novel early stage drug candidates with the goal to outlicense
to a strategic partner. With locations in the U.S., Europe, and Asia,
AMRI provides customers with a wide range of services, technologies and
cost models.
